Season 1, Episode 1
Smart KPIs for Biotechs
Sabine Hutchison and Alan Morgan discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
Listen to the full episode right now!
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabine to discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
Alan Morgan is an experienced leader in pharmaceutical services, having operated in C suite roles for 25 years. He is an advisor and consultant within Private Equity, a non-executive advisor to Excelya in Paris, non-executive chairman of Gentronix Limited (a genetic toxicology early stage CRO PE backed), and an advisor to Luure.ai , a US based AI tech startup.
Join the discussion and listen to the full episode here.
Related Episodes
Season 2 Episode 1 – Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions
Season 2, Episode 1 Bridging the Gap, Accelerating the Path to Cure with Strategic Funding SolutionsIn the first episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the inspiring Stephanie Oestreich, whose work at the Myeloma Investment...
Episode 5 – Mastering the Art of Collaboration: Principal Investigator and Biotech Dynamics
Season 1, Episode 5 Mastering the Art of Collaboration: Principal Investigator and Biotech DynamicsSabine Hutchison sits down with the incredible Viviënne van de Walle a highly respected principal investigator who brings her wealth of experience to the table, blending...
Stay Connected to Get The Latest Podcast Alerts
CUT THE CHAT - LIFE SCIENCE INSIDER
Listen Now!
An informative podcast series designed quite literally to cut the unnecessary talk and get straight to the point and heart of many life science and biotech conversations that need to happen for our industry to evolve, innovate and get smarter—faster.
0 Comments